Dana B. Shinbaum
Profile
Dana B.
Shinbaum held former positions as Vice President of Product Planning & Market Analytics at Savient Pharmaceuticals, Vice President of Business Development at Capstone Therapeutics Corp., Head of Corporate Development at VIVUS, and Product Manager of the Premarin Franchise at Wyeth Pharmaceuticals LLC.
He earned a Master's in Business Administration from Drexel University and an undergraduate degree from Lafayette College.
Former positions of Dana B. Shinbaum
| Companies | Position | End |
|---|---|---|
| VIVUS, INC. | Corporate Officer/Principal | - |
| SAVIENT PHARMACEUTICALS INC | Sales & Marketing | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
| CAPSTONE HOLDING CORP. | Corporate Officer/Principal | - |
Training of Dana B. Shinbaum
| Drexel University | Masters Business Admin |
| Lafayette College | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| CAPSTONE HOLDING CORP. | Health Technology |
| Private companies | 3 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
- Stock Market
- Insiders
- Dana B. Shinbaum
